Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
17 03 2020
Historique:
received: 15 03 2019
accepted: 23 07 2019
pubmed: 28 7 2019
medline: 7 1 2021
entrez: 28 7 2019
Statut: ppublish

Résumé

Bias arises in studies of waning vaccine effectiveness when higher-risk individuals are depleted from the at-risk population at different rates between study groups. We examined how this bias arises and how to avoid it. A reanalysis of data from California confirmed a finding of intra-season waning of influenza vaccine effectiveness.

Identifiants

pubmed: 31351439
pii: 5540005
doi: 10.1093/cid/ciz706
pmc: PMC7318775
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1484-1486

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI107721
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Clin Infect Dis. 2019 May 2;68(10):1631-1633
pubmed: 30204853
Euro Surveill. 2016 Apr 21;21(16):
pubmed: 27124420
Epidemiology. 2010 Jan;21(1):13-5
pubmed: 20010207
Euro Surveill. 2013 Jan 31;18(5):
pubmed: 23399424
Euro Surveill. 2013 Jan 31;18(5):
pubmed: 23399423
Vaccine. 2015 Jan 1;33(1):246-51
pubmed: 24962752
Epidemiology. 2017 Jan;28(1):136-144
pubmed: 27748685
AIDS. 2012 Jan 14;26(2):123-6
pubmed: 22045345
Clin Infect Dis. 2019 Jun 18;69(1):190-191
pubmed: 30561533
Demography. 1979 Aug;16(3):439-54
pubmed: 510638
Clin Infect Dis. 2019 May 2;68(10):1623-1630
pubmed: 30204855
Clin Infect Dis. 2016 Dec 29;64(5):544-550
pubmed: 28039340
Vaccine. 2017 Oct 13;35(43):5799-5807
pubmed: 28941618

Auteurs

G Thomas Ray (GT)

Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, Oakland.

Ned Lewis (N)

Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, Oakland.

Nicola P Klein (NP)

Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, Oakland.

Matthew F Daley (MF)

Institute for Health Research, Kaiser Permanente Colorado, Denver.
Department of Pediatrics, University of Colorado School of Medicine, Aurora.

Marc Lipsitch (M)

Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Bruce Fireman (B)

Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, Oakland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH